Roche on the up in Switzerland?

© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Roche on the up in Switzerland?

Roche, fresh from raising $32bn in Europe and the US, is continuing its grand tour of the capital markets and is in Switzerland today. It is issuing a three year international tranche at 140bp over mid-swaps and an eight year domestic at 220bp over. Bookrunners Credit Suisse and UBS have announced Sfr300m sizes for each, but market participants think the deal will exceed Sfr1bn by the end of the day. Read EuroWeek on Friday to see how it fares. Other deals this week include the Province of British Columbia’s return to the Swiss market after an absence of six and a half years as well as trades from EDF, Nestlé and the long awaited Generalitat de Valencia.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request demo or Login
  • 4,000 annual insights
  • 700+ notes and long-form analyses
  • 4 capital markets databases
  • Daily newsletters across markets and asset classes
  • 2 weekly podcasts
Gift this article